[1] |
Wang Z, Li Z, Feng D, et al. Autophagy induction ameliorates inflammatory responses in intestinal ischemia-reperfusion through inhibiting NLRP3 inflammasome activation[J]. Shock, 2019, 52:387-395.
|
[2] |
Jia Y, Cui R, Wang C, et al. Metformin protects against intestinal ischemia-reperfusion injury and cell pyroptosis via TXNIP-NLRP3-GSDMD pathway[J]. Redox Biol, 2020, 32:101534.doi:10.1016/j.redox.2020.101534.
|
[3] |
Meng S, Sun X, Juan Z, et al.Clemastine fumarate attenuates myocardial ischemia reperfusion injury through inhibition of mast cell degranulation[J]. Front Pharmacol, 2021, 12:704852.doi:10.3389/fphar.2021.704852.
|
[4] |
Yuan X, Juan Z, Zhang R, et al. Clemastine fumarate protects against myocardial ischemia reperfusion injury by activating the TLR4/PI3K/Akt signaling pathway[J]. Front Pharmacol, 2020, 11:28.doi:10.3389/fphar.2020.00028.
|
[5] |
Gubernatorova EO, Perez-Chanona E, Koroleva EP, et al. Murine model of intestinal ischemia-reperfusion injury[J]. J Vis Exp, 2016, 111:53881.doi:10.3791/53881.
|
[6] |
Nosálová V, Drábiková K, Jancinová V, et al. Protective effect of pheniramines against mesenteric ischaemia/reperfusion-induced injury[J]. Inflamm Res, 2009, 58 Suppl 1: 68-69.
|
[7] |
Zhao W, Huang X, Han X, et al. Resveratrol suppresses gut-derived NLRP3 inflammasome partly through stabiliz-ing mast cells in a rat model[J]. Mediators Inflamm 2018, 2018:6158671.doi:10.1155/2018/6158671.
|
[8] |
何明月,袁芳,刘映红.细胞焦亡及相关疾病的研究进展[J]. 基础医学与临床, 2019, 39:560-563.
|
[9] |
刘宁,王薇,张蕊,等.富马酸氯马斯汀在肺缺血/再灌注损伤中对TLR4表达的影响[J]. 实用医学杂志, 2016, 32:2988-2991.
|
[10] |
Kelley N, Jeltema D, Duan Y, et al. The NLRP3 inflammasome: An overview of mechanisms of activation and regulation[J]. Int J Mol Sci, 2019, 20:3328.doi:10.3390/ijms20133328.
|
[11] |
Yang J, Wu Y, Xu Y, et al. Dexmedetomidine resists intestinal ischemia-reperfusion injury by inhibiting TLR4/MyD88/NF-κB signaling[J]. J Surg Res, 2021, 260:350-358.
|
[12] |
Junxiu Z, Yu F, Yanyan H, et al. Mast cell activation, TLR4-NF-κB/TNF-α pathway variation in rats' intestinal ischemia-reperfusion injury and Tongxinluo's therapeutic effect[J]. Pak J Pharm Sci, 2020, 33:1599-1608.
|